PCI Approaches: Difference between revisions
Jump to navigation
Jump to search
Created page with "*Radial artery and femoral artery are two main methods to access the artery in percutaneous coronary intervention (PCI).<ref name="pmid34895950">{{cite journal| author=Writing Committee Members. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM | display-authors=etal| title=2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Asso..." |
No edit summary |
||
Line 16: | Line 16: | ||
2.[[Radial artery]] approach is recommended over the [[femoral artery]] access in [[patients]] with [[Chronic stable angina|stable ischemic heart disease]] ([[Chronic stable angina|SIHD]]) undergoing [[PCI]] due to lower rate access site [[bleeding]] and [[Blood vessel|vascular]] [[complications]]. | 2.[[Radial artery]] approach is recommended over the [[femoral artery]] access in [[patients]] with [[Chronic stable angina|stable ischemic heart disease]] ([[Chronic stable angina|SIHD]]) undergoing [[PCI]] due to lower rate access site [[bleeding]] and [[Blood vessel|vascular]] [[complications]]. | ||
|} | |} | ||
==References== | |||
{{Reflist|2}} | |||
{{Cardiac surgery procedures}} | |||
[[Category:Cardiology]] | |||
[[Category:Cardiac surgery]] | |||
{{WH}} | |||
{{WS}} |
Revision as of 09:02, 22 June 2022
- Radial artery and femoral artery are two main methods to access the artery in percutaneous coronary intervention (PCI).[1]
- The rate of PCI through radial artery catheterization has been increased over the past decade and patients usually prefer this approach more that the femoral artery access.[2][3]
- The following are the advantages of radial artery compared to the femoral artery approach:[4]
- Earlier ambulation
- Lower rate of vascular complications
- Lower rate of bleeding complications
- Better cardiovascular outcomes
- It is recommended to evaluate the possibility of future need to radial artery for bypass grafting before using it for PCI. In cases that there is a high likelihood of future CABG, discussion with the patient and the cardiac surgeon is required.[1]
- Femoral artery remains the default PCI access in centers where expertise in the transradial approach is unavailable or if the patient has any anatomic or clinical limitations.
ACA 2021 Revascularization Guideline for PCI Approaches
Class 1 Recommendation, Level of Evidence: A[1] |
1.Radial artery approach is recommended over the femoral artery access in patients with acute coronary syndromes (ACS) undergoing PCI due to lower rate of death, vascular and bleeding complications.
2.Radial artery approach is recommended over the femoral artery access in patients with stable ischemic heart disease (SIHD) undergoing PCI due to lower rate access site bleeding and vascular complications. |
References
- ↑ 1.0 1.1 1.2 Writing Committee Members. Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM; et al. (2022). "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines". J Am Coll Cardiol. 79 (2): e21–e129. doi:10.1016/j.jacc.2021.09.006. PMID 34895950 Check
|pmid=
value (help). - ↑ Masoudi FA, Ponirakis A, de Lemos JA, Jollis JG, Kremers M, Messenger JC; et al. (2017). "Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries". J Am Coll Cardiol. 69 (11): 1427–1450. doi:10.1016/j.jacc.2016.12.005. PMID 28025065.
- ↑ Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P; et al. (2011). "Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial". Lancet. 377 (9775): 1409–20. doi:10.1016/S0140-6736(11)60404-2. PMID 21470671.
- ↑ Ferrante G, Rao SV, Jüni P, Da Costa BR, Reimers B, Condorelli G; et al. (2016). "Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease: A Meta-Analysis of Randomized Trials". JACC Cardiovasc Interv. 9 (14): 1419–34. doi:10.1016/j.jcin.2016.04.014. PMID 27372195.